Sort by
Refine Your Search
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Regulatory Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
, and scholarly activities. In partnership with Northeastern University, Takeda Pharmaceutical Company is offering a two-year Global Medical Affairs fellowship, based in Cambridge, MA (Boston area). About
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Medical Affairs TTR fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
Global Medical Information fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative
-
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
Affairs PharmD fellowship based in Boston. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals is a biotechnology company developing and commercializing life-changing therapies for people living with
-
- Plasma Derived Therapy fellowship, based in Cambridge, MA. About Takeda Takeda has been translating science into breakthrough medicines for 240 years. Every step of the way, our teams have worked together
-
Affairs PharmD fellowship, based remotely. About Abbott Diabetes Care As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our
-
Global Medical Affairs fellowship, based in Waltham, MA. About Apellis Pharmaceuticals Apellis is delivering life-changing medicines across a broad range of serious diseases through the complement cascade